Exhibit 99.1

 

Joint Filing Agreement

 

The undersigned hereby agree that the Statement on Schedule 13G dated July 28, 2017 with respect to the shares of Common Stock of ContraFect Corporation, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

 

Dated: July 28, 2017

 

BIOTECHNOLOGY VALUE FUND, L.P. BVF INC.
     
By: BVF Partners L.P., its general partner By: /s/ Mark N. Lampert
By: BVF Inc., its general partner   Mark N. Lampert
      President
By:

/s/ Mark N. Lampert

     
  Mark N. Lampert    
  President /s/ Mark N. Lampert
    MARK N. LAMPERT
     
BIOTECHNOLOGY VALUE FUND II, L.P.  
     
By: BVF Partners L.P., its general partner  
By: BVF Inc., its general partner  
     
By:

/s/ Mark N. Lampert

   
  Mark N. Lampert  
  President  
     
     
BVF PARTNERS L.P.  
     
By: BVF Inc., its general partner  
     
By:

/s/ Mark N. Lampert

   
  Mark N. Lampert  
  President  
     
     
BVF PARTNERS OS LTD.  
     
By: BVF Partners L.P., its sole member  
By: BVF Inc., its general partner  
     
By:

/s/ Mark N. Lampert

   
  Mark N. Lampert  
  President  
     
     
Biotechnology Value Trading Fund OS LP  
     
By: BVF Partners L.P., its investment manager  
By: BVF Inc., its general partner  
     
By:

/s/ Mark N. Lampert

   
  Mark N. Lampert  
  President